Already a Bloomberg.com user?
Sign in with the same account.
SINPHAR PHARMA said unconsolidated sales in April rose 15.58% to NT$150,551,000 from NT$130,262,000, according to a statement filed to the Taiwan Stock Exchange.
(Figures are in thousands of New Taiwan dollars)
4/2012 4/2011 Sales 150,551 130,262 YOY% 15.58%
-----------------Year-to-date----------------- Sales 538,878 546,262 YOY% -1.35% =================================================================